Kythera Newsroom

Current Release

KYTHERA Biopharmaceuticals to Release First Quarter 2014 Operating Results

April 24, 2014

Calabasas, Calif., April 24, 2014 – KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced it will release its first quarter 2014 operating results and will host an investor call and webcast at 4:30 p.m. ET on Thursday, May 8, 2014.

Individuals interested in participating in the call should dial (877) 344-3890 (U.S. and Canada) or (760) 666-3770 (international) using conference ID number 32367527. To access the webcast, please visit the Investors section of KYTHERA's website at www.kytherabiopharma.com.

The call will be available for replay via telephone starting May 8, 2014, at approximately 5:30 p.m. ET, running through 11:59 p.m. ET on May 14, 2014. To listen to the replay, dial  (855) 859-2056  (U.S. and Canada) or (404) 537-3406  (international) using conference ID number 32367527. The archived webcast will be available on KYTHERA's website for seven days beginning approximately one hour after the call has completed.

About KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA’s product candidate, ATX-101, is currently in late stage clinical development for the reduction of submental fat, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring. 

###

Investor Contact
Heather Rowe
Associate Director, Investor Relations
hrowe@kytherabiopharma.com

Permalink